RENE
Income statement / Annual
Last year (2024), Cartesian Growth Corporation II's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Cartesian Growth Corporation II's net income was $8.21 M.
See Cartesian Growth Corporation II,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
-$2.03 M
|
-$685.00 K
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.04 M
|
$2.03 M
|
$685.06 K
|
$14.91 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$1.04 M
|
$2.03 M
|
$685.06 K
|
$14.91 K
|
| Cost And Expenses |
-$1.04 M
|
$2.03 M
|
$685.06 K
|
$14.91 K
|
| Interest Income |
$8.13 M
|
$11.64 M
|
$2.85 M
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
$0.00
|
$14.91 K
|
| EBITDA |
$8.21 M |
$11.44 M |
-$2.39 M |
$0.00 |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$9.24 M
|
$13.47 M
|
$5.61 M
|
$0.00
|
| Income Before Tax |
$8.21 M
|
$11.44 M
|
$4.93 M
|
-$14.91 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
$8.21 M
|
$11.44 M
|
$4.93 M
|
-$14.91 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
| EPS |
0.56 |
0.41 |
0.24 |
-0.0026 |
| EPS Diluted |
0.56 |
0.41 |
0.17 |
-0.0005 |
| Weighted Average Shares Out |
$14.57 M
|
$27.72 M
|
$20.62 M
|
$5.75 M
|
| Weighted Average Shares Out Diluted |
$14.57 M
|
$27.72 M
|
$28.75 M
|
$28.75 M
|
| Link |
|
|
|
|
